Cancer Treatment Response Differences in Pediatric and Adult Cancers
DOI:
https://doi.org/10.54097/j8gxq228Keywords:
Cancer; Childhood; Pediatric cancer; leukemia; Immunotherapy.Abstract
There are significant differences between childhood and adult cancers in a number of ways, including causes, treatments, and response to treatment. Childhood cancers are often associated with factors such as germline predisposition, genetic mutations, viral infections, and exposure to toxic substances. In contrast, adult cancers may be more influenced by factors such as family history, long-term exposure to radiation, and poor lifestyle habits. Although both childhood and adult cancers may be treated with chemotherapy, radiotherapy, and immunotherapy, treatment for children requires special attention to dose optimization and minimization of long-term side effects. In addition, the treatment of pediatric cancers presents some special challenges. The relatively low incidence of childhood cancers, the large tumor heterogeneity, and the fact that the needs and responses of each child may be different have led to relatively slow progress in pediatric oncology research. At the same time, due to the immature functioning of body systems in children during development, treatment requires more careful consideration of various possible side effects and implications. Therefore, this article first analyzes the differences in the causes of cancer between children and adults, then, explores the differences in cancer treatment between the two, and finally, emphasizes the need for collaborative efforts to address these challenges, improve access to care, and increase survival rates for pediatric patients with cancer.
Downloads
References
Gröbner S. N., Worst B. C., Weischenfeldt J., et al. The landscape of genomic alterations across childhood cancers. Nature, 2018, 555(7696): 321-327.
Dimaras H., Corson T.W., Cobrinik D., et al. Retinoblastoma, Nature Reviews Disease Primer, 2015, 1(1): 15021.
Hasaart K.A., Bertrums E.J., Manders F., er al. Increased risk of leukaemia in children with Down syndrome: A somatic evolutionary view. Expert Reviews in Molecular Medicine, 2021, 23.
Li C, Zhang JF, Pan PC, et al. Humanistic Health Management and Cancer: Associations of Psychology, Nutrition, and Exercise with Cancer Progression and Pathogenesis. Advanced Science, 2024, 2400665.
Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven Publishers, 1997, 38.
Davidoff A.M. Pediatric oncology. Seminars in Pediatric Surgery, 2010, 19(3): 225–233.
McEachron T.A., & Helman L.J. Recent advances in pediatric cancer research. Cancer Research, 2021, 81(23): 5783-5799.
Bo L., Wang Y., Li Y., et al. The battlefield of chemotherapy in pediatric cancers. Cancers, 2023, 15(7): 1963.
Kattner P., Strobel H., Khoshnevis N., et al. Compare and contrast: Pediatric cancer versus adult malignancies. Cancer and Metastasis Reviews, 2019, 38(4): 673-682.
Sara K.S., Elizabeth M.H., Seth M.S. et al. Adverse events following CAR T-Cell therapy: a single institution retrospective analysis of toxicities following CAR T-cell therapy for children and young adults with relapsed refractory b-cell acute lymphoblastic leukemia. Blood, 2021, 138: 1731.
Sassen S.D.T., Zwaan C.M., van der Sluis, et al. Pharmacokinetics and population pharmacokinetics in pediatric oncology. Pediatric Blood & Cancer, 2019, 67(4).
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







